Literature DB >> 18461976

Dietary polyphenols as topoisomerase II poisons: B ring and C ring substituents determine the mechanism of enzyme-mediated DNA cleavage enhancement.

Omari J Bandele1, Sara J Clawson, Neil Osheroff.   

Abstract

Dietary polyphenols are a diverse and complex group of compounds that are linked to human health. Many of their effects have been attributed to the ability to poison (i.e., enhance DNA cleavage by) topoisomerase II. Polyphenols act against the enzyme by at least two different mechanisms. Some compounds are traditional, redox-independent topoisomerase II poisons, interacting with the enzyme in a noncovalent manner. Conversely, others enhance DNA cleavage in a redox-dependent manner that requires covalent adduction to topoisomerase II. Unfortunately, the structural elements that dictate the mechanism by which polyphenols poison topoisomerase II have not been identified. To resolve this issue, the activities of two classes of polyphenols against human topoisomerase IIalpha were examined. The first class was a catechin series, including (-)-epigallocatechin gallate (EGCG), (-)-epigallocatechin (EGC), (-)-epicatechin gallate (ECG), and (-)-epicatechin (EC). The second was a flavonol series, including myricetin, quercetin, and kaempferol. Compounds were categorized into four distinct groups: EGCG and EGC were redox-dependent topoisomerase II poisons, kaempferol and quercetin were traditional poisons, myricetin utilized both mechanisms, and ECG and EC displayed no significant activity. On the basis of these findings, a set of rules is proposed that predicts the mechanism of bioflavonoid action against topoisomerase II. The first rule centers on the B ring. While the C4'-OH is critical for the compound to act as a traditional poison, the addition of -OH groups at C3' and C5' increases the redox activity of the B ring and allows the compound to act as a redox-dependent poison. The second rule centers on the C ring. The structure of the C ring in the flavonols is aromatic and planar and includes a C4-keto group that allows the formation of a proposed pseudo ring with the C5-OH. Disruption of these elements abrogates enzyme binding and precludes the ability to function as a traditional topoisomerase II poison.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18461976      PMCID: PMC2737509          DOI: 10.1021/tx8000785

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  98 in total

1.  Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase II.

Authors:  F H Drake; G A Hofmann; H F Bartus; M R Mattern; S T Crooke; C K Mirabelli
Journal:  Biochemistry       Date:  1989-10-03       Impact factor: 3.162

2.  Proliferation- and cell cycle-dependent differences in expression of the 170 kilodalton and 180 kilodalton forms of topoisomerase II in NIH-3T3 cells.

Authors:  R D Woessner; M R Mattern; C K Mirabelli; R K Johnson; F H Drake
Journal:  Cell Growth Differ       Date:  1991-04

3.  Double-stranded DNA cleavage/religation reaction of eukaryotic topoisomerase II: evidence for a nicked DNA intermediate.

Authors:  E L Zechiedrich; K Christiansen; A H Andersen; O Westergaard; N Osheroff
Journal:  Biochemistry       Date:  1989-07-25       Impact factor: 3.162

4.  Purification of topoisomerase II from amsacrine-resistant P388 leukemia cells. Evidence for two forms of the enzyme.

Authors:  F H Drake; J P Zimmerman; F L McCabe; H F Bartus; S R Per; D M Sullivan; W E Ross; M R Mattern; R K Johnson; S T Crooke
Journal:  J Biol Chem       Date:  1987-12-05       Impact factor: 5.157

5.  Proliferation-dependent regulation of DNA topoisomerase II in cultured human cells.

Authors:  Y H Hsiang; H Y Wu; L F Liu
Journal:  Cancer Res       Date:  1988-06-01       Impact factor: 12.701

6.  Inducible overexpression, purification, and active site mapping of DNA topoisomerase II from the yeast Saccharomyces cerevisiae.

Authors:  S T Worland; J C Wang
Journal:  J Biol Chem       Date:  1989-03-15       Impact factor: 5.157

7.  Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II.

Authors:  J Markovits; C Linassier; P Fossé; J Couprie; J Pierre; A Jacquemin-Sablon; J M Saucier; J B Le Pecq; A K Larsen
Journal:  Cancer Res       Date:  1989-09-15       Impact factor: 12.701

Review 8.  1993 Robert R. deVilliers Lecture. Chromosome translocations: dangerous liaisons.

Authors:  J D Rowley
Journal:  Leukemia       Date:  1994-04       Impact factor: 11.528

9.  Site-specific DNA cleavage by mammalian DNA topoisomerase II induced by novel flavone and catechin derivatives.

Authors:  C A Austin; S Patel; K Ono; H Nakane; L M Fisher
Journal:  Biochem J       Date:  1992-03-15       Impact factor: 3.857

10.  Plasma concentrations of phyto-oestrogens in Japanese men.

Authors:  H Adlercreutz; H Markkanen; S Watanabe
Journal:  Lancet       Date:  1993-11-13       Impact factor: 79.321

View more
  31 in total

1.  Salivary α-amylase, serum albumin, and myoglobin protect against DNA-damaging activities of ingested dietary agents in vitro.

Authors:  M Zulfiquer Hossain; Kalpesh Patel; Scott E Kern
Journal:  Food Chem Toxicol       Date:  2014-05-16       Impact factor: 6.023

2.  Phytochemicals as Anticancer and Chemopreventive Topoisomerase II Poisons.

Authors:  Adam C Ketron; Neil Osheroff
Journal:  Phytochem Rev       Date:  2014-03-01       Impact factor: 5.374

3.  Inhibition of human DNA topoisomerase IIα by two novel ellipticine derivatives.

Authors:  Kendra R Vann; Yavuz Ergün; Sevil Zencir; Serkan Oncuoglu; Neil Osheroff; Zeki Topcu
Journal:  Bioorg Med Chem Lett       Date:  2016-02-15       Impact factor: 2.823

4.  6,6'-Dihydroxythiobinupharidine as a poison of human type II topoisomerases.

Authors:  Esha D Dalvie; Jacob Gopas; Avi Golan-Goldhirsh; Neil Osheroff
Journal:  Bioorg Med Chem Lett       Date:  2019-06-04       Impact factor: 2.823

Review 5.  The Interactions between Polyphenols and Microorganisms, Especially Gut Microbiota.

Authors:  Małgorzata Makarewicz; Iwona Drożdż; Tomasz Tarko; Aleksandra Duda-Chodak
Journal:  Antioxidants (Basel)       Date:  2021-01-28

Review 6.  Resveratrol mobilizes endogenous copper in human peripheral lymphocytes leading to oxidative DNA breakage: a putative mechanism for chemoprevention of cancer.

Authors:  S M Hadi; M F Ullah; A S Azmi; A Ahmad; U Shamim; H Zubair; H Y Khan
Journal:  Pharm Res       Date:  2010-01-30       Impact factor: 4.200

7.  Effects of Secondary Metabolites from the Fungus Septofusidium berolinense on DNA Cleavage Mediated by Human Topoisomerase IIα.

Authors:  Kendra R Vann; Güner Ekiz; Sevil Zencir; Erdal Bedir; Zeki Topcu; Neil Osheroff
Journal:  Chem Res Toxicol       Date:  2016-02-26       Impact factor: 3.739

8.  Oxidative metabolites of curcumin poison human type II topoisomerases.

Authors:  Adam C Ketron; Odaine N Gordon; Claus Schneider; Neil Osheroff
Journal:  Biochemistry       Date:  2012-12-26       Impact factor: 3.162

Review 9.  Topoisomerase II and leukemia.

Authors:  Maryjean Pendleton; R Hunter Lindsey; Carolyn A Felix; David Grimwade; Neil Osheroff
Journal:  Ann N Y Acad Sci       Date:  2014-02-03       Impact factor: 5.691

10.  Bioflavonoids cause DNA double-strand breaks and chromosomal translocations through topoisomerase II-dependent and -independent mechanisms.

Authors:  Donna Goodenow; Faith Emmanuel; Chase Berman; Mark Sahyouni; Christine Richardson
Journal:  Mutat Res       Date:  2020-01-22       Impact factor: 2.433

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.